Stanley J. Goldsmith
#207,594
Most Influential Person Across History
Stanley J. Goldsmith's AcademicInfluence.com Rankings
Download Badge
Medical
Why Is Stanley J. Goldsmith Influential?
(Suggest an Edit or Addition)Stanley J. Goldsmith's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. (2010) (489)
- Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer. (2005) (442)
- The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Well-Differentiated Neuroendocrine Tumors of the Jejunum, Ileum, Appendix, and Cecum (2010) (430)
- PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease. (2002) (371)
- Clinical role of FDG PET in evaluation of cancer patients. (2003) (356)
- Possible axonal regrowth in late recovery from the minimally conscious state. (2006) (315)
- Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. (1998) (313)
- Phase II Study of Lutetium-177–Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer (2013) (305)
- Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer. (2004) (299)
- Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas. (2005) (246)
- Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen. (2003) (244)
- The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0* (2012) (213)
- Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors. (2007) (209)
- Total-hip arthroplasty: periprosthetic indium-111-labeled leukocyte activity and complementary technetium-99m-sulfur colloid imaging in suspected infection. (1990) (208)
- Comparison of fluorine‐18 fluorodeoxyglucose positron emission tomography and Ga‐67 scintigraphy in evaluation of lymphoma (2002) (208)
- In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen. (2000) (203)
- First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer (2013) (199)
- PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. (2004) (186)
- Infected knee prosthesis: diagnosis with In-111 leukocyte, Tc-99m sulfur colloid, and Tc-99m MDP imaging. (1991) (172)
- 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma. (2003) (170)
- FDG‐PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease (2006) (169)
- Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma. (2005) (162)
- Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor. (2003) (155)
- Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen. (2003) (155)
- Radionuclide diagnosis of vertebral osteomyelitis: indium-111-leukocyte and technetium-99m-methylene diphosphonate bone scintigraphy. (1991) (151)
- Radial and vertebral bone density in white and black women: evidence for racial differences in premenopausal bone homeostasis. (1989) (151)
- Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide. (2001) (149)
- Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects. (1989) (145)
- Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen. (2003) (143)
- Detection of bony metastases of androgen-independent prostate cancer by PET-FDG. (1996) (139)
- Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears? (2000) (139)
- Radioimmunotherapy of lymphoma: Bexxar and Zevalin. (2010) (137)
- Pharmacokinetics and biodistribution of 111In- and 177Lu-labeled J591 antibody specific for prostate-specific membrane antigen: prediction of 90Y-J591 radiation dosimetry based on 111In or 177Lu? (2005) (131)
- PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. (2004) (128)
- Anti–prostate‐Specific membrane antigen‐based radioimmunotherapy for prostate cancer (2010) (125)
- Radioimmunotherapy of Prostate Cancer Using 90Y- and 177Lu-Labeled J591 Monoclonal Antibodies: Effect of Multiple Treatments on Myelotoxicity (2005) (121)
- 99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Metastatic Prostate Cancer (2014) (121)
- Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma. (2008) (105)
- Chemistry and biological behavior of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy. (1993) (104)
- Spectrum of exercise thallium-201 myocardial perfusion imaging in patients with chest pain and normal coronary angiograms. (1979) (101)
- Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis. (2013) (101)
- Biodistribution, dosimetry, and clinical evaluation of technetium-99m ethyl cysteinate dimer in normal subjects and in patients with chronic cerebral infarction. (1989) (100)
- Prediction of myelotoxicity based on bone marrow radiation-absorbed dose: radioimmunotherapy studies using 90Y- and 177Lu-labeled J591 antibodies specific for prostate-specific membrane antigen. (2005) (92)
- Flare on bone scintigraphy following Taxol chemotherapy for metastatic breast cancer. (1994) (90)
- Diagnosis of Musculoskeletal Infection Using Combined In‐111 Labeled Leukocyte and Tc‐99m SC Marrow Imaging (1992) (87)
- PET/CT Imaging and Radioimmunotherapy of Prostate Cancer. (2011) (84)
- Clinically proven radiopharmaceuticals for infection imaging: mechanisms and applications. (2009) (84)
- Radioimmunoassay: review of basic principles. (1975) (83)
- Fractionated radioimmunotherapy with 90Y‐clivatuzumab tetraxetan and low‐dose gemcitabine is active in advanced pancreatic cancer (2012) (78)
- Imaging Inflammation in a Patient with Epilepsy Due to Focal Cortical Dysplasia (2013) (76)
- Gaucher's disease type 1: assessment of bone involvement by CT and scintigraphy. (1986) (75)
- The SNM Practice Guideline for Somatostatin Receptor Scintigraphy 2.0* (2011) (73)
- Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): Studies in nude mice (2004) (71)
- Can noninvasive exercise test criteria identify patients with left main or 3-vessel coronary disease after a first myocardial infarction? (1983) (71)
- SNM Practice Guideline for Breast Scintigraphy with Breast-Specific γ-Cameras 1.0* (2010) (70)
- Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody. (2016) (70)
- Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations. (1988) (67)
- The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment. (2001) (66)
- Detection of abnormalities in febrile AIDS patients with In-111-labeled leukocyte and Ga-67 scintigraphy. (1989) (65)
- Phase 1/2 study of fractionated dose lutetium‐177–labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic castration‐resistant prostate cancer (2019) (63)
- Malignant external otitis: early scintigraphic detection. (1984) (63)
- Pneumocystis carinii pneumonia studied by gallium-67 scanning. (1985) (62)
- Can exercise electrocardiography and thallium-201 myocardial imaging exclude the diagnosis of coronary artery disease? Bayesian analysis of the clinical limits of exclusion and indications for coronary angiography. (1982) (61)
- Receptor imaging: competitive or complementary to antibody imaging? (1997) (59)
- Quantification of valve regurgitation by radionuclide angiography before and after valve replacement surgery. (1981) (59)
- Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model. (2008) (56)
- Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents (2013) (54)
- PET imaging of leptin biodistribution and metabolism in rodents and primates. (2009) (53)
- Specificity and sensitivity of distinctive chest radiographic and/or 67Ga images in the noninvasive diagnosis of sarcoidosis. (1993) (52)
- SPECT evaluation of lumbar spondylolysis and spondylolisthesis. (1994) (51)
- Cyclophosphamide, vincristine, and prednisone followed by tositumomab and iodine-131-tositumomab in patients with untreated low-grade follicular lymphoma: eight-year follow-up of a multicenter phase II study. (2010) (50)
- Nuclear medicine imaging of lung cancer. (2000) (50)
- 99mTc-Pertechnetate Scintigraphy as an Aid in the Diagnosis of Breast Masses1 (1973) (45)
- Noninvasive detection of left ventricular dysfunction with a portable electrocardiographic gated scintillation probe device. (1981) (44)
- Targeted Radionuclide Therapy: A Historical and Personal Review. (2020) (44)
- Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancer. (1999) (43)
- Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae. (1986) (42)
- The utility of monoclonal antibodies in the imaging of prostate cancer. (2002) (42)
- Bone SPECT in patients with persistent back pain after lumbar spine surgery. (1989) (42)
- Clinical applications of fusion imaging in oncology. (1994) (42)
- Intracarotid dehydrocholate infusion: a new method for prolonged reversible blood-brain barrier disruption. (1983) (41)
- Noninvasive imaging of 99mtechnetium-labeled low density lipoprotein uptake by tendon xanthomas in hypercholesterolemic patients. (1990) (39)
- Extrapulmonary Sites of Radiogallium Accumulation in Sarcoidosis (1990) (39)
- Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma (2018) (38)
- Peripheral Facial Nerve Palsy after High-Dose Radioiodine Therapy in Patients with Papillary Thyroid Carcinoma (1994) (38)
- Role of nuclear medicine in the evaluation of the solitary pulmonary nodule. (2000) (37)
- Indium-111-labeled leukocyte scintigraphy in hemodialysis access-site infection. (1990) (36)
- Low density lipoprotein receptor-independent hepatic uptake of a synthetic, cholesterol-scavenging lipoprotein: implications for the treatment of receptor-deficient atherosclerosis. (1988) (35)
- Phase II trial of 177Lutetium radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 (177Lu- J591) in patients (pts) with metastatic castrate-resistant prostate cancer (metCRPC) (2008) (34)
- Determination of immunoreactive fraction of radiolabeled monoclonal antibodies: what is an appropriate method? (2004) (33)
- Bremsstrahlung radiation exposure from pure β-ray emitters (1999) (33)
- Update on nuclear medicine imaging of neuroendocrine tumors. (2009) (33)
- Positron emission tomography in lymphoma: comparison with computed tomography and Gallium-67 single photon emission computed tomography. (2000) (33)
- Studies of the hepatocellular uptake of the hepatobiliary scintiscanning agent 99mTc-DISIDA. (1986) (32)
- Subsequent therapy can be administered after tositumomab and iodine I‐131 tositumomab for non‐Hodgkin lymphoma (2006) (31)
- Effect of blood-brain barrier and blood-tumor barrier modification on central nervous system liposomal uptake. (1993) (29)
- Reduced Bone Mass in Women With Premenstrual Syndrome (1995) (29)
- Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate Cancer (2013) (29)
- 99mTc-low density lipoprotein: intracellularly trapped radiotracer for noninvasive imaging of low density lipoprotein metabolism in vivo. (1990) (28)
- Investigation of the role of the base in the synthesis of [18F]FLT. (2007) (28)
- Etoposide-induced blood-brain barrier disruption. Effect of drug compared with that of solvents. (1984) (27)
- Assessing collateral cerebral perfusion with technetium-99m-HMPAO SPECT during temporary internal carotid artery occlusion. (1993) (27)
- Clinical utility of radiolabeled monoclonal antibodies in prostate cancer. (2006) (27)
- Postoperative Changes on Brain SPECT Imaging After Aneurysmal Subarachnoid Hemorrhage A Potential Pitfall in the Evaluation of Vasospasm (1994) (27)
- The role of FDG-PET imaging in the management of lymphoma. (2004) (27)
- Indium-111 platelet kinetics in normal human subjects: tropolone versus oxine methods. (1986) (25)
- Visualization of myocardial metastasis of carcinoid tumor by indium-111-pentetreotide. (1996) (24)
- Somatostatin-receptor imaging in lymphoma. (1995) (24)
- Radon update: facts concerning environmental radon: levels, mitigation strategies, dosimetry, effects and guidelines. SNM Committee on Radiobiological Effects of Ionizing Radiation. (1994) (24)
- (90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. (2015) (24)
- Delayed biliary-to-bowel transit in cholescintigraphy after cholecystokinin treatment. (1990) (24)
- Deconvolution using orthogonal polynomials in nuclear medicine: a method for forming quantitative functional images from kinetic studies. (1990) (24)
- Role of ln-111 Labeled Leukocyte Scintigraphy in the Diagnosis of Intracerebral Lesions (1991) (23)
- Phase I trial of fractionated-dose 177lutetium radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 (177Lu-J591) in patients (pts) with metastatic castration-resistant prostate cancer (metCRPC). (2010) (23)
- Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer (2005) (23)
- Nuclear oncology : diagnosis and therapy (2001) (23)
- Use of Radiopharmaceuticals in Diagnostic Nuclear Medicine in the United States: 1960–2010 (2015) (22)
- Hybrid SPECT/CT Imaging in Clinical Practice (2006) (21)
- Appearance of acute gouty arthritis on indium-111-labeled leukocyte scintigraphy. (1990) (21)
- Multiple myeloma: 18F-FDG-PET/CT and diagnostic imaging. (2015) (21)
- To ablate or not to ablate: issues and evidence involved in 131I ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma. (2011) (19)
- Comparative Physical and Pharmacologic Characteristics of Iodine-131 and Yttrium-90: Implications for Radioimmunotherapy for Patients with Non-Hodgkin's Lymphoma (2003) (19)
- Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomas (2015) (18)
- Low-density lipoprotein (LDL) distribution shown by 99mtechnetium-LDL imaging in patients with myeloproliferative diseases. (1989) (18)
- Accuracy and precision of regional multiharmonic Fourier analysis of gated blood-pool images. (1984) (18)
- 99m Tc-pertechnetate scintigraphy as an aid in the diagnosis of breast masses. (1973) (17)
- Quantification of cardiac conduction abnormalities using segmental vector Fourier analysis of radionuclide gated blood pool scans. (1983) (16)
- Gallium-67 citrate uptake in cryptococcal thyroiditis in a homosexual male. (1985) (16)
- FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma (2008) (16)
- Effect of intracarotid etoposide on opening the blood-brain barrier. (1984) (16)
- Early assessment of radiation response using a novel functional imaging modality -- [18F]fluorocholine PET (FCH-PET): a pilot study. (2012) (15)
- Targeting metastatic prostate cancer [PCa] in patients with 123I-MIP1072 & 123I-MIP1095 (2009) (14)
- Diffuse pulmonary uptake of indium-111-labeled leukocytes in drug-induced pneumonitis. (1992) (14)
- Radioactive Iodine Therapy of Differentiated Thyroid Carcinoma: Redesigning the Paradigm (2016) (14)
- The SNM Practice Guideline for Therapy of Thyroid Disease with 131 I 3.0* (2011) (14)
- Acute effects of radiation therapy on indium-111-labeled leukocyte uptake in bone marrow. (1989) (14)
- SPECT and Lumbar MRI in Back Pain with Emphasis on Changes in End Plates in Association with Disc Degeneration (1998) (14)
- Bremsstrahlung radiation exposure from pure beta-ray emitters. (1999) (13)
- The role of gallium and labeled leukocyte scintigraphy in the AIDS patient. (1995) (13)
- Less is More: The Impact of Multidisciplinary Thyroid Conference on the Treatment of Well-Differentiated Thyroid Carcinoma (2018) (13)
- Systemic biodistribution of radioiodinated interleukin-2 in the rat. (1989) (13)
- Thyroid uptake of liquid versus capsule 131I tracers in hyperthyroid patients treated with liquid 131I. (1999) (12)
- Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement (2007) (11)
- 67Ga-transferrin and 67Ga-lactoferrin binding to tumor cells: Specific versus nonspecific glycoprotein-cell interaction (2004) (11)
- Radiochemical analysis of Tc-99m human serum albumin with high-pressure liquid chromatography: concise communication. (1982) (11)
- In vivo stability of ferric hydroxide macroaggregates (FHMA). Is it a suitable carrier for radionuclides used in synovectomy? (1990) (11)
- Gallium Scintigraphy in Bone Infarction: Correlation with Bone Imaging (1984) (11)
- Gallium scanning in differentiating malignant from benign asbestos-related pleural disease. (1986) (10)
- Preoperative parathyroid adenoma localization by the technetium‐thallium subtraction scan (1986) (10)
- Nuclear Medicine Therapy (2019) (10)
- Durable remissions from fludarabine followed by the iodine I-131 tositumomab Bexxar therapeutic regimen for patients with previously untreated follicular non-Hodgkin's lymphoma (NHL). (2004) (10)
- Phase I trial of docetaxel/prednisone plus fractionated dose radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody 177lu-J591 in patients with metastatic, castration-resistant prostate cancer (mCRPC). (2014) (10)
- Durable remissions from fludarabine followed by the iodine I-131 tositumomab Bexxar therapeutic regimen for patients with previously untreated follicular non-Hodgkin's lymphoma (NHL) (2004) (10)
- Ventilation-perfusion mismatch due to obstruction of pulmonary vein. (1981) (10)
- Nuclear Medicine Practices in the 1950s through the Mid-1970s and Occupational Radiation Doses to Technologists from Diagnostic Radioisotope Procedures (2014) (10)
- A dose-escalation study of tositumomab and iodine I 131 tositumomab (Bexxar) in pts with previously treated non-Hodgkin's lymphoma (NHL) with > 25% bone marrow involvement. (2004) (9)
- Final results of 2-dose fractionation of 177Lu-J591 for progressive metastatic castration-resistant prostate cancer (mCRPC). (2016) (9)
- Phase I dose-escalation study of docetaxel/predisone and fractionated 177Lu-J591 for metastatic castrate-resistant prostate cancer (metCRPC). (2010) (9)
- An overview of the diagnostic and therapeutic use of monoclonal antibodies in medicine. (2010) (9)
- Quantitative SPECT imaging with Lu-177: A physical phantom evaluation (2012) (9)
- A randomized phase II trial of 177lu radiolabeled monoclonal antibody J591 (177Lu-J591) and ketoconazole in patients (pts) with high-risk castrate biochemically relapsed prostate cancer (PC) after local therapy. (2010) (8)
- Phase 2 trial of 177Lutetium (177Lu) radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody (mAb) J591 (177Lu-J591) in patients (pts) with metastatic androgen-independent prostate cancer (AIPC). (2008) (8)
- Multiple extraosseous metastases from osteogenic sarcoma demonstrated on bone scintigraphy. (1992) (8)
- Bone Scintigraphy in Pleural Metastases of Osteogenic Sarcoma (1990) (8)
- Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab (2015) (8)
- 99mTc-MIP-1404 Planar and SPECT scan: Imaging biomarker of androgen receptor (AR) signaling and prostate specific membrane antigen (PSMA) expression. (2016) (8)
- Acute Radiation Nephritis Its Evolution on Sequential Bone Imaging (1988) (7)
- Phase II Study of Lutetium-177 – Labeled Anti-Prostate-Speci fi c Membrane Antigen Monoclonal Antibody J 591 for Metastatic Castration-Resistant Prostate Cancer (2013) (7)
- In‐111 Labeled Leukocyte Imaging in a Case of Pseudogout (1992) (7)
- Phase II study of lutetium-177 labeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 for metastatic castration-resistant prostate cancer (2013) (7)
- Tuberculous lymphadenitis In-111 leukocyte and Ga-67 imaging. (1991) (7)
- The use of technetium-99m sulfur colloid as a marker for experimental venous thrombosis: concise communication. (1981) (7)
- PSMA targeted SPECT imaging biomarker to detect local and metastatic prostate cancer (PCa): Phase I studies with 99mTc-MIP-1404 (2013) (7)
- Lymphoma imaging: nuclear medicine. (2006) (7)
- Gated blood pool scintigraphic monitoring of doxorubicin cardiomyopathy: comparison of camera and computerized probe results in 101 patients. (1986) (6)
- Indium-111-labeled leukocyte and technetium-99m-sulfur colloid uptake by a malignant fibrous histiocytoma: phagocytosis by tumor cells? (1990) (6)
- Gallium-67 uptake after breast and hip augmentation with silicone. (1992) (6)
- Tositumomab and iodine I 131 tositumomab: Efficacy and safety in 141 patients (pts) with previously untreated low-grade (LG) non-Hodgkin's lymphoma (NHL) (2005) (6)
- BremsstrahlungRadiation Exposure From Pure p-Ray Emitters (1999) (6)
- Improving insight into radiobiology and radionuclide therapy. (2004) (6)
- Tc-99m labeled small-molecule inhibitors of prostate-specific membrane antigen (PSMA): New molecular imaging probes to detect metastatic prostate adenocarcinoma (PC). (2012) (6)
- Septal myocardial perfusion imaging with thallium-201 in the diagnosis of proximal left anterior descending coronary artery disease. (1981) (6)
- Technetium-99m MDP accumulation in hepatic metastasis from osteogenic sarcoma. (1987) (6)
- Value of blood-pool subtraction in cardiac indium-111-labeled platelet imaging. (1989) (6)
- Unusual F-18 choline uptake in penile metastasis from prostate cancer. (2012) (5)
- The Real Cost of Theoretic Risk Avoidance: The Need to Challenge Unsubstantiated Concerns About 131I Therapy (2011) (5)
- Physiological influences on perfusion imaging in transient myocardial ischaemia: importance of early distribution of thallium-201. (1982) (5)
- SPECT Evaluation of Unilateral Spondylolysis (1994) (5)
- Gallium-67-citrate imaging in nuclear oncology. (1994) (5)
- Evaluation of four radiopharmaceuticals for imaging inflammation in a rabbit model of arthritis (1996) (5)
- Torsion of a Testicular Appendage in an Adult Male (1990) (5)
- Appearance of fibrous dysplasia on In-111 labeled leukocyte scintigraphy. (1991) (5)
- 177Lu-J591 monoclonal antibody (Lu-J591) therapy in metastatic castrate-resistant prostate cancer (metCRPC): Correlation of antibody-tumor targeting and treatment response (2008) (5)
- Interim results of an open-label, single-arm trial of ultratrace I-131-iobenguane in patients with metastatic pheochromocytoma/paraganglioma (Pheo). (2012) (5)
- Fractionated dose radiolabeled antiprostate specific membrane antigen (PSMA) radioimmunotherapy (177Lu-J591) with or without docetaxel for metastatic castration-resistant prostate cancer (mCRPC). (2015) (5)
- Gallium scanning in peritoneal mesothelioma. (1985) (5)
- Effect of source strength and attenuation on dual photon absorptiometry. (1989) (5)
- Wound Dressing Activity Mimicking Infection on Labeled Leukocyte Imaging (1992) (4)
- Uterine leiomyomata. Discrepancy between scintigraphic and radiographic images. (1990) (4)
- Prospective Evaluation of the World Health Organization Criteria for the Diagnosis of Polycythemia Vera (2011) (4)
- Peptides in Biomedical Sciences: Principles and Practice (1994) (4)
- Rhythmicity of human growth hormone secretion. (1970) (4)
- Hypocalcemia in metastatic bone disease: metabolic and radionuclide studies of a case. (1984) (4)
- Metastatic Prostate Cancer Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Tc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen : 99 (2014) (4)
- Cisternography and CT Scanning with 111In-DTPA in Evaluation of Posterior Fossa Arachnoid Cysts (1979) (4)
- 177Lu‐DOTA‐HuJ591: A new radiolabeled monoclonal antibody (MAb) for targeted therapy of prostate cancer (2001) (4)
- Radionuclide imaging of thoracic malignancies. (2004) (4)
- Planar imaging of positron-emitting radionuclides with a multicrystal camera. (1982) (4)
- Detection of silent left ventricular dysfunction during daily activities in coronary artery disease patients by the nuclear VEST. (1990) (4)
- Organ perfusion by dynamic scintigraphy convection-diffusion tracer kinetics in a phantom. (1992) (4)
- Comparison of the clearance of technetium-99m MAG3 and iodine-131 OIH. (1988) (4)
- Increased Focal Uptake of Tc-99m-IDA Hepatobiliary Agent by a Liver Metastasis (1981) (4)
- Invasion from Mars (1995) (4)
- SPECT imaging in the diagnosis of Budd-Chiari syndrome. (1990) (4)
- Radioimmunotherapy of Lymphoma (2012) (3)
- Current status of radiolabeled peptides in nuclear medicine diagnosis and therapy. (2002) (3)
- Fludarabine Plus I-131 Tositumomab as Initial Treatment for Follicular Lymphoma: Half of Patients In Remission at Over 10 Years Median Followup. (2010) (3)
- Imaging Multidrug Resistance in Hematological Malignancies (2001) (3)
- Effect of Patient Position on Interpretation of Lung Images Complicated by Chest Radiograph Opacities (1989) (3)
- Serial Dacryoscintigraphy Before and After Treatment with Pseudoephedrine (1989) (3)
- 2200 A PHASE 1 PILOT STUDY OF 99MTC-MIP-1404 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)/CT IMAGING IN MEN WITH PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY (2013) (3)
- Myocardial uptake of Tc-99m MDP following cardioversion. (1991) (3)
- Small molecule inhibitors of prostate specific membrane antigen (PSMA) for SPECT: Summary of phase I studies in patients with prostate cancer (PCa) (2012) (3)
- MP50-19 DOSE-FRACTIONATED ANTI-PSMA RADIOIMMUNOTHERAPY (177LU-J591) FOR MCRPC (2016) (3)
- Evaluation of 99mTc-LDL for studying lipoprotein metabolism and imaging atherosclerotic lesions in vivo (1985) (3)
- Isolated Splenic Metastasis from Rectal Carcinoma: A Rare Occurrence (2011) (3)
- The value of SPECT/CT in the setting of a normal In-WBC whole-body planar scintigram (2011) (3)
- Tc-99m labeled small-molecule inhibitors of prostate-specific membrane antigen (PSMA): New molecular imaging probes to detect metastatic prostate adenocarcinoma (PC). (2012) (3)
- 952 ANTI-PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA)-BASED RADIOIMMUNOTHERAPY FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): A DECADE OF EXPERIENCE WITH RADIOLABELED (RL)-J591 (2012) (3)
- Osteopetrosis: nuclear medicine pathophysiologic correlation. (1989) (3)
- Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 in patients (pts) with metastatic castration-resistant prostate cancer (metCRPC). (2009) (3)
- Patterns of diffusely increased skeletal radiopharmaceutical uptake. (1981) (3)
- Phase 1 Study of Radiosensitization Using Bortezomib in Patients with Relapsed Non-Hodgkin's Lymphoma Receiving Radioimmunotherapy (2011) (3)
- Complimentary roles of cardiac ultrasound and cardiovascular nuclear medicine. (1980) (3)
- Fractionated radioimmunotherapy with 90Y-clivatuzumab tetraxetan (90Y-hPAM4) plus gemcitabine (Gem) in advanced pancreatic cancer (APC) (2011) (2)
- Extra-articular knee lesion with high fluorodeoxyglucose-uptake on positron emission tomography. (2013) (2)
- Phase II trial of 177Lutetium radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 (177Lu- J591) in patients (pts) with metastatic androgen-independent prostate cancer (AIPC) (2007) (2)
- 111In-J591 scan to predict PSMA targeting and treatment response following RIT with 177Lu-J591 monoclonal antibody in patients with metastatic prostate cancer (2010) (2)
- Radionuclide Imaging of Thoracic Malignancies (2005) (2)
- Nuclear medicine imaging of lung cancer : Lung Cancer (2000) (2)
- Head and Neck Carcinoma (2020) (2)
- Non-specific binding of transferrin and lactoferrin to polystyrene culture tubes: Role of the radioligand (2004) (2)
- The SNM Practice Guideline on Breast Scintigraphy (2010) (2)
- Superiority of F-18 FDG PET over Tl-201 SPECT in the evaluation of AIDS-associated brain lesions (2006) (2)
- 90Y-DOTA-lanreotide: Dosimentry and toxicity (2000) (2)
- Image artifacts in tomographic gamma camera systems. (1973) (2)
- Tc‐99m Labaled Red Blood Cell Scinligraphy (RBC) for Hepatic Hemangioma (H): Are flow (F) & Early (E) Blood Pool (BP) Phases Necessary? (1989) (2)
- Phase 2 trial of 177Lutetium (177Lu) radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody (mAb) J591 (177Lu-J591) in patients (pts) with metastatic androgen-independent prostate cancer (AIPC) (2006) (2)
- Radioiodine Therapy in Differentiated Thyroid Carcinoma (2019) (2)
- Antiprostate-specific membrane antigen (PSMA)-based radioimmunotherapy: A combined analysis of radiolabeled-J591 studies. (2011) (2)
- Phase I dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC). (2018) (2)
- Characterization and automatic identification of ECG conduction abnormalities using segmental multiharmonic fourier analysis of gated blood-pool scintigrams (2004) (2)
- Noninvasive measurement of prostate-specific membrane antigen (PSMA) expression with radiolabeled J591 imaging: A prognostic tool for metastatic castration-resistant prostate cancer (CRPC). (2013) (2)
- /sup 111/In-platelet survival kinetics: Tropolone vs oxine method (1985) (1)
- Porcine model of complex coronary atherosclerosis (CCA) or vulnerable plaque: Role of FDG-PET to study the disease progression and assess lesion macrophage activity (2007) (1)
- Radiolabeled J591 Antibody Delivers Lethal Hit to Advanced Prostate Cancers in a Phase I Trial (2004) (1)
- [11C]PIB imaging in primary progressive aphasia and Alzheimer disease (2007) (1)
- Guest editorial: Skeletal nuclear medicine. (2015) (1)
- Phase II trial of 177lutetium radiolabeled anti-PSMA antibody J591 (177Lu-J591) for metastatic castrate-resistant prostate cancer (metCRPC): Survival update and expansion cohort with biomarkers. (2013) (1)
- Rapid F-18 labeling of peptides using aniline catalyzed oximation with [18F]FDG (2011) (1)
- The Hot Stripe Sign: An Unusual Variation (1990) (1)
- FDG PET/CT in Clinical Oncology (2012) (1)
- Etoposide Induced Blood-Brain Barrier Disruption in Rats : Duration of Opening and Histolà 3 gica ! Sequelae 1 (2006) (1)
- Multidisciplinary imaging of Budd-Chiari syndrome. (1989) (1)
- Procedure Guideline for Somatostatin Receptor (2001) (1)
- Abstract 748: Phase I trial of fractionated-dose177Lutetium radiolabeled anti-prostate-specific membrane antigen monoclonal antibody J591 (177Lu-J591) in patients with metastatic castration-resistant prostate cancer (metCRPC) (2012) (1)
- Lines from the President (1986) (1)
- Radiolabeled anti-prostate specific membrane antigen (PSMA) monoclonal antibody J591 (177Lu-J591) for nonmetastatic castration-resistant prostate cancer (CRPC): A randomized phase II trial. (2011) (1)
- Nuclear Medicine in the Diagnosis and Management of Colorectal Cancer (2002) (1)
- Use of PIB-PET in a double-blind, placebo-controlled Alzheimer's disease (AD) immunotherapy trial (2008) (1)
- Phase I dose-escalation study of fractionated-dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC). (2017) (1)
- Ejection fraction as determined by the nuclear stethoscope. (1981) (1)
- Early and late skeletal effects of radiation therapy on In-111 labeled leukocyte imaging. (1992) (1)
- Abstract 4696: Non-invasive measurement of prostate-specific membrane antigen (PSMA) expression with radiolabeled J591 imaging: a promising biomarker for PSMA-based radioimmunotherapy. (2013) (1)
- An improved gas phase module (GE TracerLab FXc) for the production of [11C]methyl iodide (2007) (1)
- The relationship of dyspnea on exertion to stress-induced thallium-201 lung uptake. (1987) (1)
- Renal scintigraphy of en bloc transplantation of pediatric kidneys. (1992) (1)
- Unusual scintigraphic findings in a thyroid adenoma. (1993) (1)
- The uterine blush on In-111 labeled leukocyte scintigraphy. (1991) (1)
- Radioimmunotherapy of Prostate Carcinoma (2013) (1)
- In‐111 Labeled Leukocyte Imaging in Intrathoracic Colitis (1992) (1)
- FDG-PET May Be Helpful in the Determination of Transformation to an Aggressive Subtype in Low-Grade Lymphoma. (2005) (1)
- In‐111 Leukocyte Imaging in Disseminated Mycobacterium Avium‐Intracellulare Infection (1992) (1)
- Molecular imaging of vulnerable plaque: Comparison of 3 PET tracers; [11C]PK11195, [18F]Fluorocholine and [18F]FDG in a porcine model of complex coronary atherosclerosis (CCA) (2007) (1)
- Original Articles TARGETING METASTATIC PROSTATE CANCER WITH RADIOLABELED MONOCLONAL ANTIBODY J591 TO THE EXTRACELLULAR DOMAIN OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (2003) (1)
- Labeled leukocyte imaging in chemical cystitis. (1993) (1)
- Parathyroid scintigraphy: Comparison of dual-tracer [Tc99m MIBI - pertechnetate] and dual-phase Tc99m MIBI imaging (2008) (1)
- Radionuclide cerebral perfusion imaging: Normal pattern (1991) (1)
- Oral presentations (2010) (0)
- Cost-Effectiveness of Lung Scanning (1976) (0)
- Scientific Highlights of the EANM Congress 1991 (1991) (0)
- Unexpected Malignancy/Second Primary (2012) (0)
- The Prisoner's Dilemma (1994) (0)
- Radionuclides and Their Application in Oncology Research (1995) (0)
- [18F]fluorocholine PET (FCH-PET) Based Adaptive Image-guided Radiation Therapy (RT): A Planning Study (2011) (0)
- O. Schober, W. Heindel, Eds. PET-CT hybrid imaging. New York/Stuttgart: Thieme; 2010, 312 pages, 616 illustrations, US$149.95; ISBN: 978-3-13-148861-9. (2011) (0)
- TH‐D‐330A‐01: Annual Gamma Camera QC: Techniques And Phantoms To Simplify The Implementation Of The NEMA NU‐1 Procedures For Tests Recommended By The ACR (2006) (0)
- Perioperative continuous monitoring of left ventricular function (LVF) in patients (PTS) undergoing noncardiac surgery (1995) (0)
- Nuclear Medicine and Nuclear War (1985) (0)
- Fractionated radioimmunotherapy (RAIT) for enhanced cumulative radiation delivery in the treatment of advanced pancreatic cancer (APC). (2010) (0)
- Initial experience with [11C]5-hydroxy-L-tryptophan [5-HTP] PET imaging studies in patients with neuroendocrine tumors [NET] (2007) (0)
- [11C]PK11195-PET to image neuroinflammation in focal epilepsy (2011) (0)
- Planar Imagingof Positron-EmittingRadionuclideswith a MulticrystalCamera (2006) (0)
- Stunning of I-131 uptake in treatment of Graves' disease: Relationship to treatment failure (2008) (0)
- Imaging the lymphomas. (2006) (0)
- Reproducibility of dual-photon absorptiometry using a clinical phantom (1985) (0)
- Metastatic Human Colonic Carcinoma: Molecular Imaging with PretargetedSPECTandPETina (2008) (0)
- Scientific highlights of the European Association of Nuclear Medicine Congress--1989. Nuclear medicine continues its innovative development. (1989) (0)
- Cerebral network abnormalities identified by FDG-PET in minimally conscious state (MCS) following severe brain injury (2008) (0)
- Running Through Life (1998) (0)
- Targeted Radionuclide Therapy of Prostate Cancer (2013) (0)
- Georg de Hevesy Nuclear Medicine Pioneer Award Citation--1986. Rosalyn S. Yalow and Solomon A. Berson. (1987) (0)
- SPECT/CT Imaging for Prostate Cancer (2016) (0)
- Paget's disease of the skull. Serendipity on gallium scintigraphy. (1990) (0)
- ln-111 Labeled Leukocyte Scintigraphy in a Case of Multifocal Candidiasis (1990) (0)
- Rosalyn S. Yalow: a personal and scientific memoir. (2012) (0)
- In-111 labeled leukocyte and Ga-67 scintigraphy in cytomegalovirus colitis. (1990) (0)
- Tracking Random Walk Systems with Vector Space Adaptive Filters (1995) (0)
- 111In LEUKOCYTE/99??Tc SULFUR COLLOID MARROW IMAGING OF JOINT ARTHROPLASTY INFECTION: REVIEW OF 100 CASES (1992) (0)
- Dose fractionation (DF) and combination radioimmunotherapy (RIT) in patients with prostate cancer using 177Lu-J591 (Lu-J591) anti-PSMA antibody and docetaxel (2011) (0)
- Radioimmunoimaging of pneumocystis carinii infection in rats (1984) (0)
- Utilization of unwashed low grade phosphate rock. (1949) (0)
- Indium-111 PlateletKinetics in NormalHuman Subjects: TropoloneVersusOxine Methods (1986) (0)
- Inhibition of ga-67 tumor uptake by transferrin and lactoferrin in nude mice bearing human malignant mesothelioma. Abstr. (1982) (0)
- Evaluation of non-invasive image derived input function obtained from dynamic PET imaging (2014) (0)
- FDG PET/CT in Clinical Oncology: Case Based Approach with Teaching Points (2012) (0)
- PET/CT Evaluation As a Prognostic Indicator In Relapsed Or Refractory Multiple Myeloma (2013) (0)
- 4-(n-[11C]methyl)Amino benzhydrazide (MM-ABAH): A new PET tracer to image atherosclerosis (2008) (0)
- Cases of Litholapaxy Performed on Children (1887) (0)
- [13N]Gemcitabine: A new PET tracer to assess gemcitabine (GT) tumor uptake (2008) (0)
- Total-Hip Arthroplasty:PeriprostheticIndium-. 111-Labeled Leukocyte Activityand Complementary Technetium-.99m-Sulfur (1990) (0)
- FDG-PET to assess anti-inflammatory treatment response in psoriasis (2013) (0)
- SU‐FF‐T‐237: Exposure Rate Calculation: Effect Of Photon Divergence Near A Radioactive Source (2006) (0)
- All about Y-90 radio-embolic therapy: Practice patterns and patient safety (2011) (0)
- Splenic SUV on FDG-PET in NHL correlates with histopathology findings at splenectomy (2007) (0)
- 1. Peripheral Facial Nerve Palsy After High-Dose Radioiodine Therapy in Patients with Papillary Thyroid Carcinoma (1995) (0)
- 123I-Ioflupane SPECT in early Parkinson syndrome (2012) (0)
- The significance of reversible and irreversible perfusion deficits in the evaluation of ischemic heart disease. (1978) (0)
- THE VALUE OF INDIUM‐111 LEUKOCYTE SCINTIGRAPHY (WBC) IN DETECTION OF UNSUSPECTED SINUSITIS (S) AND ORAL CANDIDIASIS (C) (1989) (0)
- Severe Atrophy of Right Hepatic Lobe Simulating Right Hepatic Lobectomy (1981) (0)
- Assessing Collateral CerebralPerfusion with Technetium-99m-HMPAOSPECT During Temporary Internal CarotidArtery Occlusion (1993) (0)
- Correlations between amyloid and metabolic pet imaging in cognitively normal adults with a family history of late-onset Alzheimer's disease (2011) (0)
- Head and Neck (2012) (0)
- Early Prediction of Radiation (RT)/chemoradiation (CRT) Response using a Novel Functional Imaging Method- [18F]fluorocholine Pet (FCH-PET) (2010) (0)
- Nuclear medicine: procedural and cognitive. (1989) (0)
- P138: Analysis of a native abdominal aortic aneurysm model in swine: Correlation of nuclear imaging with histological evidence of inflammation (2007) (0)
- Commentary: When Words Become “Contaminated” (1985) (0)
- MO‐G‐BRB‐02: Rosalyn S. Yalow, PhD: A Personal and Scientific Memoir (2012) (0)
- Radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 for metastatic castration-resistant prostate cancer (CRPC). (2011) (0)
- Correlation of sequential nuclear imaging with interval histological changes in a porcine abdominal aortic aneurysm model (2007) (0)
- FDG-PET versus Thallium-201 SPECT in the evaluation of putative CNS lymphoma in AIDS patients. (2006) (0)
- Evaluation of platelet thromboxane radioimmunoassay method to measure platelet life-span: Comparison with /sup 111/indium-platelet method (1985) (0)
- Sickle Cell Crisisas Evaluatedfrom Measurementsof Hydroxybutyrate Dehydrogenaseand Myoglobinin Plasma on plasma (2004) (0)
- Bone marrow scintigraphy and computed tomography in myloproliferative disease (1985) (0)
- Low level radioactive waste: what are the facts? (1989) (0)
- Technetium-99m-Sulfur Colloid Uptake by a Malignant Fibrous Histiocytoma: Phagocytosis (1990) (0)
- Comprar Nuclear Oncology | Stanley J. Goldsmith | 9781451186857 | Lippincott Williams & Wilkins (2014) (0)
- Evaluation of salt as a medium for isolation of high-level waste (1983) (0)
- FDG-PET predicts disease burden in multiple myeloma. (2016) (0)
- Dimer in Normal Subjects and in Patients with Chronic Cerebral Infarction Biodistribution , Dosimetry , and Clinical Evaluation of Technetium-99 m Ethyl Cysteinate (2006) (0)
- Atlas of PET/CT with SPECT/CT (2009) (0)
- Origin of Janus—Reply (1996) (0)
- Abstract 3971: Non-invasive assessment of prostate-specific membrane antigen (PSMA) expression as a prognostic marker in men with metastatic castration-resistant prostate cancer (mCRPC) (2016) (0)
- Pulmonary scintigraphy in surgically corrected congenital heart disease (1987) (0)
- One Year Follow-Up for the Phase I MTD Study of Ultratrace Iobenguane I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma (Pheo) (2010) (0)
- Dual-Photon Absorptiometry: Depleted Sources Inappropriate in Obese Patients with Narrow Collimation—Reply to Dr. Sorenson (1990) (0)
- Relative cerebral perfusion in rat using microPET analysis following [11C]butanol injection (2008) (0)
- Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate speci fic (2004) (0)
- The patient continued to receive prednisone, his symptoms (2006) (0)
- Value of FDG-PET in Prediction of Splenectomy Findings in Patients with Suspected or Known Lymphoma. (2006) (0)
- Targeted radioimmunotherapy (RIT) with 177Lutetium labeled J591, anti-prostate-specific membrane antigen (PSMA) monoclonal antibody: Initial results of a phase 2 trial in patients with metastatic androgen-independent prostate cancer (AIPC) (2007) (0)
- Exposure Rate Calculation: Effect of Photon Divergence Near a Radioactive Source (2006) (0)
- Time to Say Good-Bye (1998) (0)
- Usefulness of F18-FDG PET in differential diagnosis of common malignant brain tumors and in determining the unknown primary tumors presenting with brain metastases (2011) (0)
- The Useof Technetium-99mSulfurColloidas a Markerfor Experimental VenousThrombosis:ConciseCommunication (2006) (0)
- Efficacy and Safety of Tositumomab/Iodine-131 Tositumomab in the Expanded Access Study: Interim Report From Two Institutions (2001) (0)
- Fractionated dose radiolabeled anti−prostate specific membrane antigen (PSMA) radioimmunotherapy (177Lu−J591) for progressive metastatic castration−resistant prostate cancer (mCRPC). (2016) (0)
- In Praise of Fantasy (1998) (0)
- Infected hepatic metastasis. Role of In-111 leukocyte scintigraphy. (1990) (0)
- COMBINED 111In LABELED LEUKOCYTE & 99MTC SULFUR COLLOID IMAGING IN HIP REPLACEMENT INFECTION (1990) (0)
- Development of a Radiolabeled Monoclonal Antibody to Prostate-Specific Membrane Antigen (2005) (0)
- Tc-99m LABELED ANTI-GRANULOCYTE ANTIBODY (AGA): PHARMACOKINETICS AND RADIATION DOSIMETRY (1992) (0)
- Lumbar puncture. Potential pitfall in In-111 labeled leukocyte scintigraphy. (1991) (0)
- Reliable index of tumor targeting in RIT with 177Lu-J591 monoclonal antibody in patients with metastatic prostate cancer (2011) (0)
- The role of radionuclide imaging in metastatic disease: the Mount Sinai experience. (1980) (0)
- Utility of decreased FDG SUV as a response and prognostic indicator in multiple myeloma therapy with BiRD (2008) (0)
- Localization of parathyroid adenomata by thallium-201 and technetium-99m subtraction scintigraphy. (1988) (0)
- Something borrowed, something blue. (1994) (0)
- Clinical value of SPECT/CT vs SPECT images in In-111 WBC (In-WBC) scintigraphy (2007) (0)
- Red cell mass (RCM) determination is essential for proper diagnosis of early stage polycythemia vera (PV) (2012) (0)
- The Whole Is Greater Than the Sum of Its Parts (1996) (0)
- “Take Your Time, Doctor” (1996) (0)
- Urologic Tumors Bladder (2012) (0)
- Abstract B98: Final results of a randomized phase Ib study of fractionated 90Y-clivatuzumab tetraxetan in patients with metastatic pancreatic cancer having at least two prior therapies (2015) (0)
- Abstract CT140: Pilot study of “hyperfractionated” anti-prostate specific membrane antigen (PSMA) radioimmunotherapy (177Lu-J591) for progressive metastatic castration-resistant prostate cancer (mCRPC) (2016) (0)
- FDG-PET Demonstrates Different Metabolic Activities among Lymphoma Subtypes. (2005) (0)
- Hodgkin’s Disease and Lymphomas (2007) (0)
- TH7E SIGNIFICANCE OF REVERSIBLE AND IRREVERSIBLE PERFUSION DEFICITS IN THE EVALUATION OF ISCHEMIC HEART DISEASE (2007) (0)
- RAD1OCHEMISTRY AND RADIOPHARMACEU11CALS RadiochemicalAnalysisof Tc-99m HumanSerumAlbuminwith High-Pressure LiquidChromatography:ConciseCommunication (2006) (0)
- Newsline Begins Third Year in JNM (1987) (0)
- Nuclear Neurology 1996: From Medical Technology to Medical Practice (1996) (0)
- The Prisoner's Dilemma and Medical Economics (1994) (0)
- SPECT strengths hold up against PET for long term (2005) (0)
- Performance evaluation of a SFOV solid state imaging system (2006) (0)
- Prediction of response to therapy with clarithromycin/lenalidomide/dexamethasone (BIRD) in multiple myeloma using FDG-PET. (2006) (0)
- Solitary Pulmonary Nodule (SPN), Chest Mass (2012) (0)
- Essentials of nuclear medicine imaging, F.A. Mettler, M.J. Guiberteau (Eds.). Saunders/Elsevier, Philadelphia, PA (2006), 512 pages, over 600 illustrations, US$95.00, ISBN: 0-7216-0201-0. (2007) (0)
- Delayed gastric emptying (DGE) causes feeding failure(FF) in children born small for gestational age (SGA) with in utero growth retardation (IUGR) and russell-silver syndrome (RSS) (2003) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Stanley J. Goldsmith?
Stanley J. Goldsmith is affiliated with the following schools:
